Fangda, Davis Polk and Conyers advised InnoCare Pharma Limited on the deal. InnoCare Pharma Limited executed a successful listing on the Shanghai Stock Exchange’s STAR Market. InnoCare...
InnoCare Pharma Limited’s Listing on Shanghai Stock Exchange
Interra Acquisition Corporation’s SPAC Listing
Davis Polk has advised Interra Acquisition Corporation, while Freshfields Bruckhaus Deringer has advised ABCI Capital and J.P. Morgan. ABCI Capital and J.P. Morgan, the joint sponsors...
Taibang Biologic Group’s $300 Million Equity Raising
Davis Polk advised Taibang Biologic Group on the transaction. Taibang Biologic Group (previously listed as China Biologic Products Holdings on the Nasdaq Global Select Market under...
Tuya’s HK$140 Million Initial Public Offering
Maples Group and Davis Polk & Wardwell acted as legal advisers to Tuya as to Hong Kong and US laws and Jia Yuan Law Offices as...
Li Auto’s $2 Billion At-The-Market Offering
Davis Polk, working alongside King & Wood Mallesons advised the sales agents in the offering. Li Auto Inc. announced its at-the-market offering program, under which Li Auto may...
Laekna Therapeutics’ $61 Million Series D Financing
Davis Polk advised Laekna Therapeutics in the transaction. Laekna Therapeutics completed its $61 million Series D financing led by CS Capital with support from Worldstar, and Infinity...
CNOOC’s US$4.38 Billion Initial Public Offering
Davis Polk advised CNOOC Limited on the IPO. CNOOC Limited (CNOOC) announced its initial public offering and listing on the Shanghai Stock Exchange. The gross proceeds...
CANbridge Pharmaceuticals Inc.’s HK$604 Million IPO
Harneys, alongside Davis Polk & Wardwell and King & Wood Mallesons, acted as Cayman Islands counsel to CANbridge Pharmaceuticals Inc. Kirkland & Ellis and Tian Yuan...
ANE (Cayman) Ltd.’s US$127 Million Listin On The HKSE
Freshfields Bruckhaus Deringer advised the joint sponsors and the underwriters in the global offering and listing of shares of ANE (Cayman) Inc. on the Hong Kong...
Yili Group’s HK$6.25 Billion Acquisition of 34.33% of Ausnutria Dairy
Davis Polk advised Inner Mongolia Yili Industrial Group on the deal. Inner Mongolia Yili Industrial Group Co., Ltd executed the acquisition of 34.33% of Ausnutria Dairy...
MicroTech Medical’s US$249 Million Initial Public Offering
Davis Polk advised MicroTech Medical, while Clifford Chance has advised the joint sponsors involved in the transaction. The Hangzhou-based firm offers diabetes therapy and manufactures medical...
Broncus Holding’s HK$1.55 Billion Initial Public Offering
Davis Polk, Gleiss Lutz and Maples and Calder advised Broncus Holding Corporation, while Dentons Hong Kong advised Goldman Sachs and Haitong International Capital in the transaction....